[March 05, 2015]

Research and Markets: Gaucher's Disease Pipeline Review 2015 - 15 Drug Profiles & 17 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/rwvzds/gauchers_disease) has announced the addition of the "Gaucher's Disease - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Gaucher's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gaucher's Disease and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strenthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• Amicus Therapeutics, Inc.
• Bioorganic Research and Services S.A.
• Biosidus S.A.
• Dong-A Socio Group
• Genzyme Corporation
• greenovation Biotech GmbH
• ISU ABXIS Co., Ltd.
• JCR Pharmaceuticals Co., Ltd.
• Lixte Biotechnology Holdings, Inc.
• Neuraltus Pharmaceuticals, Inc.
• Pharming Group N.V.
• Protalix BioTherapeutics, Inc.
• ReGenX Biosciences, LLC
• The International Biotechnology Center (IBC) Generium
• UAB Profarma

Drug Profiles

• afegostat tartrate + ERT
• ambroxol
• BNT-001
• eliglustat tartrate
• Gene therapy to Activate Glucocerebrosidase for Gaucher's Disease
• Glucocerebrosidase
• JR-101
• LB-201
• LB-205
• NP-003
• PRX-112
• Recombinant Enzyme for Gaucher's Disease
• Recombinant Enzyme to Replace Beta-Cerebrosidase for Gaucher's Disease
• Small Molecule to Activate Beta-Galactosidase for GM1 Gangliosidosis and Gaucher's Disease
• Small Molecule to Activate Glucocerebrosidase for Parkinson's, Gaucher's and Neurodegenerative Diseases
• Small Molecules to Activate Glucocerebrosidase for Gaucher's and Parkinson's Disease
• Small Molecules to Inhibit Alpha-Glucosidase for Diabetes and Gaucher's Disease

For more information visit http://www.researchandmarkets.com/research/rwvzds/gauchers_disease.

[ Back To TMCnet.com's Homepage ]